Serum antibodies against ßH-crystallins in the American Cocker Spaniel.

OBJECTIVE: To detect antibodies for lens ßH-crystallins in the serum from the American Cocker Spaniel (ACS) presenting with and without cataracts and with and without uveitis. ANIMAL STUDIED: Seventy-three American Cocker Spaniels and six normal Beagles. PROCEDURES: Sera were collected from 73 ACSs, including those with normal lenses and those with cataracts, or uveitis. Fractionated, normal Beagle lens ßH-crystallins were separated by one- or two-dimensional electrophoresis. The separated lens ßH-crystallins were used on immunoblots as sentinel substrates against which the ACS sera were tested for the presence of antibodies against ßH-crystallins. RESULTS: Sera from approximately two-thirds of study animals contained antibodies to some ßH-crystallin polypeptides, but reactivity varied among patients. Contrary to some hypotheses, serum antibodies to groups of ßH-crystallins did not relate to the stages of cataract. However, detailed analysis by two-dimensional immunoblotting and mass spectrometry showed that three spots originating from ßA1-crystallin were detected only in sera from cataract patients. CONCLUSION: Serum antibodies to ßA1-crystallin may be associated with the development of cataract.

High incidence of antibodies to lens proteins in sera from patients with uveitis.

BACKGROUND: Uveitis is an intraocular inflammatory disease in which autoimmune reactions have been discussed in playing an important role. Many data in this respect derived from the animal model of "experimental autoimmune uveitis", where several organ-specific autoantigens have been described such as the retinal S-antigen and the interphotoreceptor retinoid-binding protein. However, their diagnostic and pathogenic role in humans has been controversially discussed. In recent studies, the possible relevance of betaB1-crystallin, present in lens and ciliary body, has been outlined. We, therefore, wanted to analyse whether sera from patients with uveitis might contain antibodies to lens proteins METHODS: Human lenses from cadaveric eyes were shock frozen, homogenized, and resuspended. The resulting suspension (human lens protein fraction--HLPF) was analyzed for antigenicity by ELISA and Western blotting with patients' sera. A total of 165 patients with uveitis, 54 patients with scleritis and episcleritis, 56 patients with other eye diseases, and 112 healthy blood donors were studied. RESULTS: Twenty-six (49%) of the 53 patients with anterior uveitis, 17 (32%) of the 53 patients with intermediate uveitis and 7 (22%) of 32 patients with posterior uveitis reacted in the ELISA with the HLPF. Antibodies to lens antigens were detected in one-third of patients with panuveitis and retinal vasculitis. In contrast, only 12% of the healthy blood donors were positive in the ELISA. The number of patients with an autoimmune response to alpha-crystallins in Western blot predominated in all investigated groups. CONCLUSIONS: These data indicate that antibodies to lens proteins occur in a high incidence in sera from patients with uveitis. Forty-nine percent of the patients with anterior uveitis and only 12% of healthy controls were positive in the ELISA. In our groups of patients and controls the autoantibodies reacted in the Western blot predominantly with alpha-crystallin. Further studies are required to analyze in more detail the clinical and etiopathogenetic relevance of the antilens antibodies in uveitis.

Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.

PURPOSE: This study used an immunochemical approach aimed to detect the glycated crystallins (beta- and gamma-crystallin) in rat lens and their circulating specific autoantibodies in serum during the course of cataractogenesis. METHODS: Streptozocin (STZ; 55 mg/kg body mass) induced diabetic male Wistar/NIN rats (2-3 months old) and control nondiabetic rats were used for this study. Plasma glucose, glycated hemoglobin and body weight were evaluated on day zero, and at the interval of every two weeks up to the eighth week of post-injection in both the groups. Other biochemical parameters, such as the levels of nonprotein sulfhydryl (-SH) groups and the activity of gamma-glutamyl transpeptidase (gamma-GT) in lens proteins were also estimated. Cataract progress was monitored by measuring the advanced glycation end product (AGE)-like fluorophores in both intact lens as well as in lens homogenate employing digital based image analysis and spectrofluorimetric methods. Similarly, the polyclonal antibodies specific to beta-glycated-, gamma-glycated-, beta-, and gamma-crystallins were used to determine the concentration of respective immunogens in lens by noncompetitive ELISA and their respective circulating antibodies by antibody capture assay. The profile of glycated lens protein (soluble and insoluble fractions) during the course of cataractogenesis was assessed by the western blot technique. RESULTS: STZ induced diabetic rats showed typical signs of diabetes (hyperglycemia, increased water and food intake with no increase in body weight). Biochemical analysis of total lens protein showed a significant (p = <0.001) decrease in the levels of nonprotein -SH groups. The activity of lenticular gamma-GT in diabetic rats was found to be unaltered as compared to the control group. Digital analysis of intact lens illustrated a positive correlation (r(2)=0.888) with the formation of AGE-like fluorophores during the course of cataractogenesis. A similar trend was also observed in the levels of AGE-like fluorophores in the total lens homogenate of diabetic animals during the course of cataractogenesis. The concentration of beta- and gamma-glycated-crystallins in the rat lens (soluble and insoluble fractions) was analyzed by non-competitive ELISA. The concentration of beta- and gamma-glycated-crystallins were found to be enhanced by the end of week eight, as compared to the control group. Concomitantly, crystallin-specific (beta- and gamma-glycated-crystallin) autoantibodies were also detected in the serum of the diabetic rats from week two onwards. Western blot analysis indicated the formation of enhanced glycated lens crystallins (beta- and gamma-crystallin) in the insoluble fraction. CONCLUSIONS: The following was observed during the course of cataractogenesis: (1) there was an enhanced formation of AGEs-like fluorophores in intact lens; (2) beta- and gamma-glycated-crystallin levels increased in the rat lens (insoluble fraction) by the end of week eight; and (3) release of these glycated lens proteins into peripheral circulation resulted in the production of autoantibodies to beta- and gamma-glycated-crystallins that could be detected as early as week two, after induction of diabetic status in experimental rats.